Key Highlights

  • Atlassian (NASDAQ:TEAM) shares rose 4.10% to USD 138.46 on November 20, 2026.
  • Cloud Revenue grew 31% in the latest quarter.
  • Fiscal Q2 cloud growth is guided to about 27%.
  • Co-founder Mike Cannon-Brookes disclosed about USD 8 million of insider buying.

A Bounce After the Earnings Reset

Atlassian (NASDAQ:TEAM), the maker of Jira, Confluence and other team collaboration software, rose 4.10% to USD 138.46 on November 20, 2026. No new announcement appeared on the day. The stock closed at USD 133.01 on November 19 after a 1.51% fall, and it dropped 5.98% to USD 140.98 on November 17 during a broad software rout, as investors worry that seat-based application software will lose out to AI agents. The 52-week range runs from USD 56.01 to USD 229.96. Co-founder Mike Cannon-Brookes disclosed about USD 8 million of insider buying under a trading plan, and UBS initiated at Neutral with a USD 150 target. Intuit's weak outlook has deepened anxiety about older software names. The company has also been shifting customers from self-hosted Data Center products to its cloud platform, a change that lifts cloud growth in the short term but removes high-margin license revenue over time. The mixture helps explain why headline growth and the reaction to guidance diverged.

Guidance Slowdown Versus a Strong Quarter

The first quarter beat expectations on revenue and EPS, cloud revenue grew 31% and remaining performance obligations rose 44%. The reset came from guidance: cloud growth is expected to slow to about 27% in the second quarter and about 26% for fiscal 2027, and subscription ARR growth is guided to about 18.5% from 22.5%. The bullish view is that slower guidance reflects tougher comparisons and the lapping of the DX Acquisition and hybrid deals, so it looks prudent rather than a peak. The bearish view is that the Data Center wind-down is a structural drag, and Truist cut its target to USD 200 from USD 250. The market Capitalization is USD 34.79 billion and the forward price to earnings ratio is 25.32. Remaining performance obligations, which measure contracted revenue yet to be recognized, rose 44%, so customers have committed to future spending even as the market worries about seat counts. Management has described the guidance as conservative, and investors will test that claim at the next report.

Risks: AI Monetization and a High Trailing Multiple

The key question is whether Rovo, the company's AI product, can drive ARR growth fast enough to offset slower seat growth. The trailing price to earnings ratio of 406.47 reflects very small net profit, so valuation rests on forward earnings, where the ratio is 25.32. After the sharp sell-off, valuation looks lower, but the shares remain far below the 52-week high. Further software sector news, including competitors' outlooks and AI product launches, can move the stock sharply either way. Investors will watch the next report for evidence that AI monetization offsets seat pressure. Truist's lower target reflects reduced growth expectations, while UBS's USD 150 target sits close to the current price. A split among firms like this shows the market has not settled on how much AI will help or hurt collaboration software, so the stock may stay volatile for some time.

Where Things Stand

Atlassian (NASDAQ:TEAM) bounced as buyers returned after a reset that followed guidance for slower cloud growth. Insider buying, a quarterly beat and a lower valuation support the rebound. Against that, cloud growth is guided down to about 27%, the Data Center wind-down is a drag and AI disruption fears weigh on seat-based software. The next report will show whether Rovo can offset the slowdown. A single bounce does not settle the debate over seat-based software.